Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

TET3 regulates terminal cell differentiation at the metabolic level.

  • Mulet, Isabel
  • Grueso-Cortina, Carmen
  • Cortés-Cano, Mireia
  • Gerovska, Daniela
  • Wu, Guangming
  • Iakab, Stefania Alexandra
  • Jimenez-Blasco, Daniel
  • Curtabbi, Andrea
  • Hernansanz-Agustín, Pablo
  • Ketchum, Harmony
  • Manjarrés-Raza, Israel
  • Wunderlich, F Thomas
  • Bolaños, Juan Pedro
  • Dawlaty, Meelad M
  • Hopf, Carsten
  • Enríquez, José Antonio
  • Araúzo-Bravo, Marcos J
  • Tapia, Natalia
TET-family members play a critical role in cell fate commitment. Indeed, TET3 is essential to postnatal development due to yet unknown reasons. To define TET3 function in cell differentiation, we have profiled the intestinal epithelium at single-cell level from wild-type and Tet3 knockout mice. We have found that Tet3 is mostly expressed in differentiated enterocytes. In the absence of TET3, enterocytes exhibit an aberrant differentiation trajectory and do not acquire a physiological cell identity due to an impairment in oxidative phosphorylation, specifically due to an ATP synthase assembly deficiency. Moreover, spatial metabolomics analysis has revealed that Tet3 knockout enterocytes exhibit an unphysiological metabolic profile when compared with their wild-type counterparts. In contrast, no metabolic differences have been observed between both genotypes in the stem cell compartment where Tet3 is mainly not expressed. Collectively, our findings suggest a mechanism by which TET3 regulates mitochondrial function and, thus, terminal cell differentiation at the metabolic level.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Proprotein convertases blockage up-regulates specifically metallothioneins coding genes in human colon cancer stem cells

  • Gerovska, Daniela
  • García Gallastegui, Patricia
  • Descarpentrie, Jean
  • Crende Arruabarrena, Olatz
  • Casado Andrés, María del Rosario
  • Martín, Ander
  • Eguia, Jokin
  • Khatib, Abdel-Majid
  • Araúzo Bravo, Marcos J.
  • Badiola Echaburu, Iker
Despite continuous exertion made, colon cancer still represents a major health problem and its incidence continues being high worldwide. There is growing evidence in support of the cancer stem cells (CSCs) being central in the initiation of this cancer, and CSCs have been the focus of various studies for the identification of new ways of treatment. Lately, the proprotein convertases (PCs) were reported to regulate the maturation and expression of various molecules involved in the malignant phenotype of colon cancer cells, however, the identity of the molecules regulated by these serine proteases in CSCs is unknown. In this study, we used the general PCs inhibitor, the Decanoyl-RVKR-chloromethylketone (Decanoyl-RVKR-CMK) that inhibits all the PCs found in the secretory pathway, and analyzed its effect on CSCs using RNA-seq analysis. Remarkably, from the only 9 up-regulated genes in the human SW620-derived sphere-forming cells, we identified 7 of the 11 human metallothioneins, all of them localized on chromosome 16, and zinc related proteins as downstream effectors of the PCs. The importance of these molecules in the regulation of cell proliferation, differentiation and chemoresistance, and their reported potential tumor suppressor role and loss in colon cancer patients associated with worse prognosis, suggests that targeting PCs in the control of the, University of the Basque Country, Spain, Project ref.: PPGA20/22. D.G. and M.J.A.-B. have been supported by Grants of the Ministry of Economy and Competitiveness, Spain, MINECO Grant BFU2016-77987-P and Instituto de Salud Carlos III (AC17/00012) Grant co-funded by the European Union (Eracosysmed/H2020 Grant Agreement No. 643271) and European Union (H2020-FETOPEN, Project 899417). D.G., M.J. A.-B. and I.B. have been supported by Grants Health Department of the Basque Government (Spain), RIS3 call, Exp. No. 2020333039 and 2020333001.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon Tumors

  • Descarpentrie, Jean
  • Araúzo Bravo, Marcos J.
  • He, Zongsheng
  • François, Alexia
  • González, Alvaro
  • García Gallastegui, Patricia
  • Badiola Echaburu, Iker
  • Evrard, Serge
  • Pernot, Simon
  • Creemers, John W. M.
  • Khatib, Abdel-Majid
Proprotein convertases or PCs are known to regulate the malignant phenotype of colon cancer cells by different mechanisms, but their effects on cancer stem cells (CSCs) have been less widely investigated. Here, we report that PCs expression is altered in colon CSCs, and the inhibition of their activity reduced colon CSCs growth, survival, and invasion in three-dimensional spheroid cultures. In vivo, repression of PCs activity by the general PC inhibitors α1-PDX, Spn4A, or decanoyl-RVKR-chloromethylketone (CMK) significantly reduced tumor expression levels of the stem cell markers LGR5 and NANOG that are associated with reduced tumor xenografts. Further analysis revealed that reduced tumor growth mediated by specific silencing of the convertase Furin in KRAS or BRAF mutated-induced colon tumors was associated with reduced expression of LGR5 and NANOG compared to wild-type KRAS and BRAF tumors. Analysis of various calcium regulator molecules revealed that while the calcium-transporting ATPase 4 (ATP2B4) is downregulated in all the Furin-silenced colon cancer cells, the Ca2+-mobilizing P2Y receptors, was specifically repressed in BRAF mutated cells and ORAI1 and CACNA1H in KRAS mutated cells. Taken together, our findings indicate that PCs play an important role in the malignant phenotype of colon CSCs and stem cell markers’ expression and highlight PCs repression, particularly of Furin, to target colon tumors with KRAS or BRAF mutation., This research was funded by La Region Nouvelle Aquitaine, Siric Brio, Ligue Contre le Cancer, Planete Vegetal and INSERM. M.J.A.-B. was supported by a grant PID2020-119715GB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, and by the European Union H2020-FETOPEN Project 899417 Circular Vision.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Triku: a feature selection method based on nearest neighbors for single-cell data

  • Ascensión, Alex M.
  • Ibáñez Solé, Olga
  • Inza Cano, Iñaki
  • Izeta Permisán, Ander
  • Araúzo Bravo, Marcos J.
Abstract BACKGROUND: Feature selection is a relevant step in the analysis of single-cell RNA sequencing datasets. Most of the current feature selection methods are based on general univariate descriptors of the data such as the dispersion or the percentage of zeros. Despite the use of correction methods, the generality of these feature selection methods biases the genes selected towards highly expressed genes, instead of the genes defining the cell populations of the dataset. RESULTS: Triku is a feature selection method that favors genes defining the main cell populations. It does so by selecting genes expressed by groups of cells that are close in the k-nearest neighbor graph. The expression of these genes is higher than the expected expression if the k-cells were chosen at random. Triku efficiently recovers cell populations present in artificial and biological benchmarking datasets, based on adjusted Rand index, normalized mutual information, supervised classification, and silhouette coefficient measurements. Additionally, gene sets selected by triku are more likely to be related to relevant Gene Ontology terms and contain fewer ribosomal and mitochondrial genes. CONCLUSION: Triku is developed in Python 3 and is available at https://github.com/alexmascension/triku., This work was supported by grants from Instituto de Salud Carlos III (AC17/00012 and PI19/01621), cofunded by the Euro- pean Union (European Regional Development Fund/European Sci- ence Foundation, Investing in your future) and the 4D-HEALING project (ERA-Net program EracoSysMed, JTC-2 2017); Diputación Foral de Gipuzkoa, and the Department of Economic Devel- opment and Infrastructures of the Basque Government (KK- 2019/00006, KK-2019/00093); European Union FET project Cir- cular Vision (H2020-FETOPEN, Project 899417), Ministry of Sci- ence and Innovation of Spain; and PID2020-119715GB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe. A.M.A. was supported by a Basque Govern- ment Postgraduate Diploma fellowship (PRE_2020_2_0081), and O.I.S. was supported by a Postgraduate Diploma fellowship from la Caixa Foundation (identification document 100010434; code LCF/BQ/IN18/11660065).
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

An Integrative Omics Approach Reveals Involvement of BRCA1 in Hepatic Metastatic Progression of Colorectal Cancer

  • Gerovska, Daniela
  • Larrinaga Embeita, Gorka
  • Solano Iturri, Jon Danel
  • Márquez Clavijo, Joana
  • García Gallastegui, Patricia
  • Khatib, Abdel-Majid
  • Poschmann, Gereon
  • Stühler, Kai
  • Armesto, María
  • Lawrie, Charles
  • Badiola Echaburu, Iker
  • Araúzo Bravo, Marcos J.
(1) Background & Aims: The roles of different cells in the tumor microenvironment (TME) are critical to the metastatic process. The phenotypic transformation of the liver cells is one of the most important stages of the hepatic metastasis progression of colorectal cancer (CRC). Our aim was to identify the major molecules (i.e., genes, miRNAs and proteins) involved in this process. (2) Methods: We isolated and performed whole-genome analysis of gene, miRNA, and protein expression in three types of liver cells (Ito cells, Kupffer cells, and liver sinusoidal endothelial cells) from the TME of a murine model of CRC liver metastasis. We selected the statistically significant differentially expressed molecules using the Student’s t-test with Benjamini-Hochberg correction and performed functional statistically-significant enrichment analysis of differentially expressed molecules with hypergeometric distribution using the curated collection of molecular signatures, MSigDB. To build a gene-miRNA-protein network centered in Brca1, we developed a software package (miRDiana) that collects miRNA targets from the union of the TargetScan, MicroCosm, mirTarBase, and miRWalk databases. This was used to search for miRNAs targeting Brca1. We validated the most relevant miRNAs with real-time quantitative PCR. To investigate BRCA1 protein expression, we built tissue microarrays (TMAs) from hepatic metastases of 34 CRC patients. (3) Results: Using integrated omics analyses, we observed that the Brca1 gene is among the twenty transcripts simultaneously up-regulated in all three types of TME liver cells during metastasis. Further analysis revealed that Brca1 is the last BRCA1-associated genome surveillance complex (BASC) gene activated in the TME. We confirmed this finding in human reanalyzing transcriptomics datasets from 184 patients from non-tumor colorectal tissue, primary colorectal tumor and colorectal liver metastasis of the GEO database. We found that the most probable sequence of cell activation during metastasis is Endothelial→Ito→Kupffer. Immunohistochemical analysis of human liver metastases showed the BRCA1 protein was co-localized in Ito, Kupffer, and endothelial cells in 81.8% of early or synchronous metastases. However, in the greater part of the metachronous liver metastases, this protein was not expressed in any of these TME cells. (4) Conclusions: These results suggest a possible role of the co-expression of BRCA1 in Ito, Kupffer, and sinusoidal endothelial cells in the early occurrence of CRC liver metastases, and point to BRCA1 as a potential TME biomarker., D.G. and M.J.A.-B. have been supported by Grants DFG113/18 from Diputación Foral de Gipuzkoa (DFG), Spain, Ministry of Economy and Competitiveness, Spain, MINECO Grant BFU2016-77987-P and Instituto de Salud Carlos III (AC17/00012) Grant co-funded by the European Union (Eracosysmed/H2020 Grant Agreement No. 643271) and European Union (H2020-FETOPEN, Project 899417). D.G., M.J.A.-B. and I.B. have been supported by Grants Health Department of the Basque Government (Spain), RIS3 call, Exp. No. 2020333039 and 2020333001.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

GeromiRs Are Downregulated in the Tumor Microenvironment during Colon Cancer Colonization of the Liver in a Murine Metastasis Model

  • Gerovska, Daniela
  • García Gallastegui, Patricia
  • Crende Arruabarrena, Olatz
  • Márquez Clavijo, Joana
  • Larrinaga Embeita, Gorka
  • Unzurrunzaga, Maite
  • Araúzo Bravo, Marcos J.
  • Badiola Echaburu, Iker
Cancer is a phenomenon broadly related to ageing in various ways such as cell cycle deregulation, metabolic defects or telomerases dysfunction as principal processes. Although the tumor cell is the main actor in cancer progression, it is not the only element of the disease. Cells and the matrix surrounding the tumor, called the tumor microenvironment (TME), play key roles in cancer progression. Phenotypic changes of the TME are indispensable for disease progression and a few of these transformations are produced by epigenetic changes including miRNA dysregulation. In this study, we found that a specific group of miRNAs in the liver TME produced by colon cancer called geromiRs, which are miRNAs related to the ageing process, are significantly downregulated. The three principal cell types involved in the liver TME, namely, liver sinusoidal endothelial cells, hepatic stellate (Ito) cells and Kupffer cells, were isolated from a murine hepatic metastasis model, and the miRNA and gene expression profiles were studied. From the 115 geromiRs and their associated hallmarks of aging, which we compiled from the literature, 75 were represented in the used microarrays, 26 out of them were downregulated in the TME cells during colon cancer colonization of the liver, and none of them were upregulated. The histone modification hallmark of the downregulated geromiRs is significantly enriched with the geromiRs miR-15a, miR-16, miR-26a, miR-29a, miR-29b and miR-29c. We built a network of all of the geromiRs downregulated in the TME cells and their gene targets from the MirTarBase database, and we analyzed the expression of these geromiR gene targets in the TME. We found that Cercam and Spsb4, identified as prognostic markers in a few cancer types, are associated with downregulated geromiRs and are upregulated in the TME cells., This work was supported by grants from Instituto de Salud Carlos III (AC17/00012), cofounded by the European Union projects (European Regional Development Fund/European Science Foundation, Investing in your future), (ERA-Net program EracoSysMed, JTC-2 2017) and (H2020-FETOPEN, Circular Vision, Project 899417); Diputación Foral de Gipuzkoa and the Department of Economic Development and Infrastructures of the Basque Government (DFG109/20) and the Department of Economic Development and Infrastructures of the Basque Government (DFG109/Grants Health Department of the Basque Government (Spain), RIS3 call, Exp. No. 2020333039 and 2020333001. 20).
eBiltegia. Repositorio Institucional de Mondragon Unibertsitatea
Publication Artículo científico (JournalArticle)

Chronic disease incidence explained by stepwise models and co-occurrence among them

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

TET3 regulates terminal cell differentiation at the metabolic level

  • Mulet, Isabel
  • Grueso-Cortina, Carmen
  • Cortes-Cano, Mireia
  • Gerovska, Daniela
  • Wu, Guangming
  • Iakab, Stefania Alexandra
  • Jiménez-Blasco, Daniel
  • Curtabbi, Andrea
  • Hernansanz-Agustin, Pablo
  • Ketchum, Harmony
  • Manjarres-Raza, Israel
  • Wunderlich, F Thomas
  • Bolaños, Juan P.
  • Dawlaty, Meelad M.
  • Hopf, Carsten
  • Enríquez, José Antonio
  • Arauzo-Bravo, Marcos J.
  • Tapia, Natalia
17 páginas, 7 figuras, TET-family members play a critical role in cell fate commitment. Indeed, TET3 is essential to postnatal development due to yet unknown reasons. To define TET3 function in cell differentiation, we have profiled the intestinal epithelium at single-cell level from wild-type and Tet3 knockout mice. We have found that Tet3 is mostly expressed in differentiated enterocytes. In the absence of TET3, enterocytes exhibit an aberrant differentiation trajectory and do not acquire a physiological cell identity due to an impairment in oxidative phosphorylation, specifically due to an ATP synthase assembly deficiency. Moreover, spatial metabolomics analysis has revealed that Tet3 knockout enterocytes exhibit an unphysiological metabolic profile when compared with their wild-type counterparts. In contrast, no metabolic differences have been observed between both genotypes in the stem cell compartment where Tet3 is mainly not expressed. Collectively, our findings suggest a mechanism by which TET3 regulates mitochondrial function and, thus, terminal cell differentiation at the metabolic level., N.T is funded by Agencia Estatal de Investigación(RYC-201416359; SAF2015-66549-R; PID2019-105920RB-100), Ayudas Fundación BBVA2016 andGeneralitat Valenciana (ACIF-2021-195). D.G. and M.J.AB. have received funding from the European Union’s Horizon 2020 Research and Innovation programme (grant agreement N° 899417), Ministerio de Ciencia e Innovación (PID2020-119715GB-I00/AEI/ 10.13039/501100011033) and Instituto de Salud Carlos III (Infrastructure of Precision Medicine associated with ScienceandTechnology(IMPaCT) of the Strategic Action in Health (iDATA-MP)). J.P.B. is funded by MICIU/ AEI (PID2022-138813OB-I00, PID2019-105699RB-I00 /10.13039/ 501100011033 and FEDER, UE), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016) and the European Union’sHorizonEurope research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY)., Peer reviewed